-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Search results for: “patient perspective”
-
IASLC Spotlight: Global Policy and Partnerships Committee
In a Q&A with ILCN, Dr. Gilberto de Lima Lopes, Committee Chair, details how the committee is working to address the most significant global challenges in lung cancer care.
-
Patient Charts: How to Carefully Manage Patient Access to Health Information
Advocate Angus Pratt explores the pros and cons of patient access to electronic health records and discusses how the emergence of AI—with human oversight—could offer a way to navigate this complex issue.
-
New Data Warrant Broader Lung Cancer Screening Guidelines
Dr. Elaine Shum said the FANSS trial data confirm the feasibility of expanding screening to high-risk individuals with no smoking history.
-
Novel ADC Shows Longest PFS to Date for EGFRm NSCLC
Investigators Wenfeng Fang, MD, PhD, and Fei Zhou, MD, PhD, share results from mono, combination studies of iza-bren. The data will be discussed during an oral abstract session Monday afternoon.
-
Adding Value to Lung Cancer Care: Targeted Therapies
In a Q&A with ILCN, Gisele Fraga Moreira discusses the role of targeted therapies in lung cancer care and managing toxicities with new treatments.
-
Meeting Highlights & Tips from the IASLC CEO
As day one of WCLC 2025 begins, Dr. Karen Kelly shares how attendees can make the most of the conference.
-
Building Solutions for Lung Cancer Care in Latin America
The LATAM workshop at WCLC 2025 spotlights multidisciplinary strategies to tackle disparities and improve outcomes across the region.
-
Impacting a Generation of Lung Cancer Research Advocates: The IASLC STARS Program
Andrew Ciupek, PhD, shares how the STARS Program supports patients with lung cancer and their families while advancing research.
-
IASLC Committee Spotlight: Multidisciplinary Clinical Science Committee
Dr. Tom Stinchcombe discusses how this new IASLC committee is aiming to define multidisciplinary care, improve global access, and support collaborative science.
-
Climate Change Increasingly Exposes Communities, Healthcare Systems to Unpredictable Circumstances
The American Cancer Society’s Dr. Leticia Nogueira says lung cancer epitomizes the severe and inescapable threats climate change pose to cancer control activities.
View ILCN Archives
Provider Resources
Popular Articles